(Q35871381)

10 August 2017

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia (English)

1 reference

10 August 2017

0 references

Stefan Verlohren

4

0 references

S Ananth Karumanchi

10

object named as

S Ananth Karumanchi

1 reference

10 August 2017

Sarosh Rana

1

1 reference

10 August 2017

Camille E Powe

2

1 reference

10 August 2017

Saira Salahuddin

3

1 reference

10 August 2017

Frank H Perschel

5

1 reference

10 August 2017

Richard J Levine

6

1 reference

10 August 2017

Kee-Hak Lim

7

1 reference

10 August 2017

Julia B Wenger

8

1 reference

10 August 2017

Ravi Thadhani

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

18 January 2012

1 reference

10 August 2017

9

1 reference

inferred from page(s)

published in

Circulation

1 reference

10 August 2017

125

1 reference

10 August 2017

911-919

1 reference

10 August 2017

7

1 reference

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Vitamins C and E to prevent complications of pregnancy-associated hypertension

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Diagnosis and management of atypical preeclampsia-eclampsia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Preterm premature rupture of the membranes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Neonatal outcome after preterm delivery for preeclampsia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Circulating angiogenic factors and the risk of preeclampsia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Prognostic Role of Uterine Artery Doppler in Patients with Preeclampsia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319742

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

14 November 2018

1 reference

12 December 2020

Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

1 reference

12 December 2020

The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice

1 reference

12 December 2020

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

1 reference

12 December 2020

Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study

1 reference

12 December 2020

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

1 reference

12 December 2020

Hypertension in pregnancy: clinical-pathological correlations and remote prognosis

1 reference

12 December 2020

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.111.054361

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference